nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—CHRM2—type 1 diabetes mellitus	0.39	0.54	CbGaD
Loxapine—ADRB1—type 1 diabetes mellitus	0.332	0.46	CbGaD
Loxapine—HTR7—umbilical artery—type 1 diabetes mellitus	0.0119	0.203	CbGeAlD
Loxapine—HTR2A—arteriole—type 1 diabetes mellitus	0.00427	0.0727	CbGeAlD
Loxapine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00304	0.0518	CbGeAlD
Loxapine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00293	0.05	CbGeAlD
Loxapine—DRD1—nerve—type 1 diabetes mellitus	0.00264	0.045	CbGeAlD
Loxapine—HTR3A—nerve—type 1 diabetes mellitus	0.00255	0.0434	CbGeAlD
Loxapine—SLC6A3—nerve—type 1 diabetes mellitus	0.00212	0.0361	CbGeAlD
Loxapine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00212	0.0361	CbGeAlD
Loxapine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00183	0.0312	CbGeAlD
Loxapine—SLC6A2—nerve—type 1 diabetes mellitus	0.00171	0.0292	CbGeAlD
Loxapine—HTR7—nerve—type 1 diabetes mellitus	0.00165	0.0281	CbGeAlD
Loxapine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00162	0.0472	CcSEcCtD
Loxapine—DRD2—nerve—type 1 diabetes mellitus	0.00156	0.0266	CbGeAlD
Loxapine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00155	0.0264	CbGeAlD
Loxapine—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00137	0.0397	CcSEcCtD
Loxapine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00133	0.0385	CcSEcCtD
Loxapine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00132	0.0225	CbGeAlD
Loxapine—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.00124	0.021	CbGeAlD
Loxapine—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00122	0.0355	CcSEcCtD
Loxapine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00122	0.0355	CcSEcCtD
Loxapine—HRH2—cardiovascular system—type 1 diabetes mellitus	0.00114	0.0194	CbGeAlD
Loxapine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00113	0.0328	CcSEcCtD
Loxapine—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00109	0.0316	CcSEcCtD
Loxapine—HTR2A—nerve—type 1 diabetes mellitus	0.00103	0.0175	CbGeAlD
Loxapine—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.00102	0.0173	CbGeAlD
Loxapine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00101	0.0294	CcSEcCtD
Loxapine—ADRA1B—kidney—type 1 diabetes mellitus	0.000971	0.0165	CbGeAlD
Loxapine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000905	0.0263	CcSEcCtD
Loxapine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000857	0.0249	CcSEcCtD
Loxapine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.000843	0.0245	CcSEcCtD
Loxapine—Asenapine—ADRB1—type 1 diabetes mellitus	0.000814	0.218	CrCbGaD
Loxapine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000782	0.0227	CcSEcCtD
Loxapine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00078	0.0227	CcSEcCtD
Loxapine—Renal failure—Ramipril—type 1 diabetes mellitus	0.000751	0.0218	CcSEcCtD
Loxapine—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00075	0.0128	CbGeAlD
Loxapine—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000746	0.0127	CbGeAlD
Loxapine—Jaundice—Ramipril—type 1 diabetes mellitus	0.000745	0.0216	CcSEcCtD
Loxapine—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.000726	0.0124	CbGeAlD
Loxapine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000713	0.0207	CcSEcCtD
Loxapine—HTR1D—kidney—type 1 diabetes mellitus	0.00071	0.0121	CbGeAlD
Loxapine—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.000705	0.012	CbGeAlD
Loxapine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000686	0.0199	CcSEcCtD
Loxapine—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000679	0.0116	CbGeAlD
Loxapine—DRD2—retina—type 1 diabetes mellitus	0.000646	0.011	CbGeAlD
Loxapine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000618	0.018	CcSEcCtD
Loxapine—Alopecia—Ramipril—type 1 diabetes mellitus	0.000606	0.0176	CcSEcCtD
Loxapine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000605	0.0103	CbGeAlD
Loxapine—CHRM3—kidney—type 1 diabetes mellitus	0.000594	0.0101	CbGeAlD
Loxapine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000592	0.0101	CbGeAlD
Loxapine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000586	0.00998	CbGeAlD
Loxapine—Tension—Ramipril—type 1 diabetes mellitus	0.000586	0.017	CcSEcCtD
Loxapine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000585	0.017	CcSEcCtD
Loxapine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000578	0.00985	CbGeAlD
Loxapine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000574	0.0167	CcSEcCtD
Loxapine—HTR7—kidney—type 1 diabetes mellitus	0.000566	0.00963	CbGeAlD
Loxapine—Tremor—Ramipril—type 1 diabetes mellitus	0.000559	0.0163	CcSEcCtD
Loxapine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000558	0.0095	CbGeAlD
Loxapine—Agitation—Ramipril—type 1 diabetes mellitus	0.000549	0.0159	CcSEcCtD
Loxapine—Cyproheptadine—CHRM2—type 1 diabetes mellitus	0.000548	0.147	CrCbGaD
Loxapine—Syncope—Ramipril—type 1 diabetes mellitus	0.000535	0.0156	CcSEcCtD
Loxapine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000534	0.0155	CcSEcCtD
Loxapine—Olanzapine—CHRM2—type 1 diabetes mellitus	0.000531	0.142	CrCbGaD
Loxapine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000525	0.0153	CcSEcCtD
Loxapine—Cough—Ramipril—type 1 diabetes mellitus	0.000521	0.0151	CcSEcCtD
Loxapine—ADRA2C—kidney—type 1 diabetes mellitus	0.00052	0.00885	CbGeAlD
Loxapine—Convulsion—Ramipril—type 1 diabetes mellitus	0.000517	0.015	CcSEcCtD
Loxapine—ADRA2C—pancreas—type 1 diabetes mellitus	0.000516	0.0088	CbGeAlD
Loxapine—Chest pain—Ramipril—type 1 diabetes mellitus	0.000508	0.0148	CcSEcCtD
Loxapine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000497	0.0144	CcSEcCtD
Loxapine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000491	0.0143	CcSEcCtD
Loxapine—Oedema—Ramipril—type 1 diabetes mellitus	0.000487	0.0142	CcSEcCtD
Loxapine—Shock—Ramipril—type 1 diabetes mellitus	0.000479	0.0139	CcSEcCtD
Loxapine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000478	0.0139	CcSEcCtD
Loxapine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000477	0.0139	CcSEcCtD
Loxapine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000475	0.0138	CcSEcCtD
Loxapine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000469	0.00798	CbGeAlD
Loxapine—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.000459	0.123	CrCbGaD
Loxapine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000455	0.0132	CcSEcCtD
Loxapine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000441	0.0128	CcSEcCtD
Loxapine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000437	0.0127	CcSEcCtD
Loxapine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000434	0.0126	CcSEcCtD
Loxapine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000433	0.0126	CcSEcCtD
Loxapine—HTR2A—retina—type 1 diabetes mellitus	0.000426	0.00726	CbGeAlD
Loxapine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000421	0.0122	CcSEcCtD
Loxapine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00042	0.0122	CcSEcCtD
Loxapine—Constipation—Ramipril—type 1 diabetes mellitus	0.000417	0.0121	CcSEcCtD
Loxapine—ADRA2A—pancreas—type 1 diabetes mellitus	0.000412	0.00702	CbGeAlD
Loxapine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000401	0.0117	CcSEcCtD
Loxapine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00036	0.00614	CbGeAlD
Loxapine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000359	0.0104	CcSEcCtD
Loxapine—HTR2A—kidney—type 1 diabetes mellitus	0.000353	0.00601	CbGeAlD
Loxapine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00035	0.0102	CcSEcCtD
Loxapine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000345	0.01	CcSEcCtD
Loxapine—Trifluoperazine—CHRM2—type 1 diabetes mellitus	0.000332	0.0891	CrCbGaD
Loxapine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000322	0.00936	CcSEcCtD
Loxapine—Quetiapine—CHRM2—type 1 diabetes mellitus	0.000322	0.0865	CrCbGaD
Loxapine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00031	0.009	CcSEcCtD
Loxapine—Rash—Ramipril—type 1 diabetes mellitus	0.000307	0.00893	CcSEcCtD
Loxapine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000307	0.00892	CcSEcCtD
Loxapine—Headache—Ramipril—type 1 diabetes mellitus	0.000305	0.00887	CcSEcCtD
Loxapine—Nausea—Ramipril—type 1 diabetes mellitus	0.000289	0.00841	CcSEcCtD
Loxapine—Clozapine—CHRM2—type 1 diabetes mellitus	0.000277	0.0744	CrCbGaD
Loxapine—Olanzapine—ALB—type 1 diabetes mellitus	0.000182	0.0488	CrCbGaD
Loxapine—Thiothixene—ALB—type 1 diabetes mellitus	0.000165	0.0442	CrCbGaD
Loxapine—Diazepam—ALB—type 1 diabetes mellitus	9.61e-05	0.0258	CrCbGaD
Loxapine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.29e-06	3.48e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.29e-06	3.48e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.27e-06	3.47e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.25e-06	3.46e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.24e-06	3.45e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.22e-06	3.44e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.21e-06	3.43e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.19e-06	3.42e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	6.17e-06	3.41e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.15e-06	3.4e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	6.12e-06	3.39e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	6.08e-06	3.36e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.04e-06	3.34e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	6.02e-06	3.33e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.98e-06	3.31e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.96e-06	3.3e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—INS—type 1 diabetes mellitus	5.95e-06	3.29e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	5.95e-06	3.29e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.93e-06	3.28e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	5.9e-06	3.26e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.88e-06	3.25e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.88e-06	3.25e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	5.86e-06	3.24e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.85e-06	3.24e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.85e-06	3.24e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.85e-06	3.23e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.84e-06	3.23e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	5.84e-06	3.23e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	5.83e-06	3.23e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.82e-06	3.22e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.82e-06	3.22e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.81e-06	3.22e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.81e-06	3.21e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.8e-06	3.21e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.8e-06	3.21e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.8e-06	3.21e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	5.79e-06	3.2e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.79e-06	3.2e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.78e-06	3.2e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.78e-06	3.2e-05	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—IL6—type 1 diabetes mellitus	5.77e-06	3.19e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.76e-06	3.19e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.75e-06	3.18e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.68e-06	3.14e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.67e-06	3.14e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.64e-06	3.12e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.62e-06	3.11e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.62e-06	3.11e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.59e-06	3.1e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.59e-06	3.09e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.59e-06	3.09e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	5.58e-06	3.09e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.57e-06	3.08e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.55e-06	3.07e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	5.54e-06	3.06e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.52e-06	3.05e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	5.51e-06	3.05e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.48e-06	3.03e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	5.46e-06	3.02e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	5.46e-06	3.02e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.44e-06	3.01e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.43e-06	3e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.41e-06	2.99e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.4e-06	2.99e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.38e-06	2.98e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.35e-06	2.96e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.33e-06	2.95e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.33e-06	2.95e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.31e-06	2.94e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.3e-06	2.93e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.29e-06	2.92e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.28e-06	2.92e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.28e-06	2.92e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	5.27e-06	2.92e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	5.27e-06	2.92e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.25e-06	2.9e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	5.22e-06	2.89e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.22e-06	2.89e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.2e-06	2.88e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.19e-06	2.87e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.17e-06	2.86e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	5.1e-06	2.82e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.1e-06	2.82e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.07e-06	2.81e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.03e-06	2.78e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.03e-06	2.78e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.03e-06	2.78e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—IL6—type 1 diabetes mellitus	5.02e-06	2.78e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	5.02e-06	2.78e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	5.01e-06	2.77e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	5.01e-06	2.77e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5e-06	2.77e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	5e-06	2.76e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	4.98e-06	2.75e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.97e-06	2.75e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.96e-06	2.74e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.95e-06	2.74e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.94e-06	2.73e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.93e-06	2.73e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.93e-06	2.73e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	4.93e-06	2.73e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.92e-06	2.72e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.91e-06	2.72e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.91e-06	2.72e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.91e-06	2.71e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.88e-06	2.7e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.86e-06	2.69e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.85e-06	2.69e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.85e-06	2.68e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.84e-06	2.67e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.83e-06	2.67e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.83e-06	2.67e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.82e-06	2.67e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.82e-06	2.66e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.81e-06	2.66e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.79e-06	2.65e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	4.79e-06	2.65e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.77e-06	2.64e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.77e-06	2.64e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.76e-06	2.63e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.75e-06	2.63e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.73e-06	2.62e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.7e-06	2.6e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.63e-06	2.56e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.57e-06	2.53e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.56e-06	2.52e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.52e-06	2.5e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.52e-06	2.5e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.5e-06	2.49e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.49e-06	2.48e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.48e-06	2.48e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.48e-06	2.48e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.48e-06	2.48e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.48e-06	2.48e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.47e-06	2.48e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.46e-06	2.47e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.46e-06	2.47e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.46e-06	2.47e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.45e-06	2.46e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.45e-06	2.46e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	4.45e-06	2.46e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.44e-06	2.46e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.43e-06	2.45e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.42e-06	2.44e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.41e-06	2.44e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.4e-06	2.44e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.4e-06	2.43e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.39e-06	2.43e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.39e-06	2.43e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.38e-06	2.42e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.37e-06	2.42e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.34e-06	2.4e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.33e-06	2.39e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.32e-06	2.39e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.32e-06	2.39e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.31e-06	2.39e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.31e-06	2.38e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.3e-06	2.38e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.3e-06	2.38e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.28e-06	2.37e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.27e-06	2.36e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.23e-06	2.34e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.21e-06	2.33e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.19e-06	2.32e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.18e-06	2.31e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.17e-06	2.31e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.16e-06	2.3e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.12e-06	2.28e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.12e-06	2.28e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.09e-06	2.27e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.08e-06	2.26e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.03e-06	2.23e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.01e-06	2.22e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.84e-06	2.13e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.8e-06	2.1e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.8e-06	2.1e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.79e-06	2.1e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.79e-06	2.1e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.78e-06	2.09e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.77e-06	2.08e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.74e-06	2.07e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.73e-06	2.07e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.73e-06	2.06e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.73e-06	2.06e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.72e-06	2.06e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.71e-06	2.05e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.71e-06	2.05e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.71e-06	2.05e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.71e-06	2.05e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	3.7e-06	2.05e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.69e-06	2.04e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.68e-06	2.04e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.67e-06	2.03e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.67e-06	2.03e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.66e-06	2.03e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.66e-06	2.02e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.65e-06	2.02e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.64e-06	2.01e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.64e-06	2.01e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.62e-06	2e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.52e-06	1.95e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.46e-06	1.92e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.46e-06	1.91e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	3.43e-06	1.9e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	3.43e-06	1.9e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.42e-06	1.89e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	3.41e-06	1.88e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.4e-06	1.88e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.4e-06	1.88e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.38e-06	1.87e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.33e-06	1.84e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.31e-06	1.83e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.29e-06	1.82e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.28e-06	1.82e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.24e-06	1.79e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.2e-06	1.77e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.19e-06	1.77e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.15e-06	1.74e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.14e-06	1.74e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.13e-06	1.73e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.12e-06	1.73e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.11e-06	1.72e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	3.1e-06	1.71e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.08e-06	1.71e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.08e-06	1.7e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.95e-06	1.63e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.91e-06	1.61e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.9e-06	1.61e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.86e-06	1.58e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.86e-06	1.58e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.85e-06	1.58e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.84e-06	1.57e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.83e-06	1.57e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.8e-06	1.55e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.8e-06	1.55e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.66e-06	1.47e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.63e-06	1.46e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.6e-06	1.44e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.54e-06	1.41e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.53e-06	1.4e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.46e-06	1.36e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.42e-06	1.34e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.23e-06	1.23e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.19e-06	1.21e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.19e-06	1.21e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.18e-06	1.21e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.18e-06	1.2e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.15e-06	1.19e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.15e-06	1.19e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2e-06	1.1e-05	CbGpPWpGaD
